Akebia Therapeutics Inc.
Exchange: IEX Type: Common Stock
Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Akebia Therapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Akebia Therapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
Xilio Therapeutics Seeks $125 Million In U.S. IPO via Seeking Alpha
Omega Healthcare Investors Inc (OHI): Price Down $-0.14 (-0.46)% Over Past Day, Up $0.02 (0.08)% Over Past Hour via ETF Daily News
Esperion Therapeutics to reduce workforce by 40% via Yahoo Finance
: Turning Point Therapeutics stock price target cut to $53 from $75 at Stifel Nicolaus via MarketWatch
Akebia Therapeutics Inc. Performance
Active Alerts for IEX:AKBA
You don't have any alerts set for IEX:AKBA.
About Akebia Therapeutics Inc.
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology.
Real-time AKBA to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.